Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

TVF Communications

- PMLiVE

AZ gets US green light for new Bydureon formulation

Its latest injectable suspension proven to reduce blood sugar levels

Novartis Gehry Building

Alcon spin-out more likely but not imminent, says Novartis

A stand-alone company could offer “additional shareholder value”

- PMLiVE

TiGenix’s Crohn’s fistulas treatment wins orphan drug status

FDA designation follows positive trial results

- PMLiVE

Patient disengagement

Understanding the why

Incanthera appoints Laura Brogden as CFO

She joins from Summ.it

- PMLiVE

PharmaLex strengthens international team

Consultancy group appoints Adrian Pencak

National Institute for Health and Care Excellence NICE logo

NICE backs GSK’s ‘bubble baby’ gene therapy

Strimvelis will treat children under the NHS for immunodeficiency

- PMLiVE

Meetings

Ensuring a box office success

- PMLiVE

GSK’s shingles vaccine Shingrix claims US approval

Becomes first alternative to Merck & Co’s Zostavax

Janssen’s quest to prevent diseases taking hold

Johan van Hoof, general manager of Janssen Vaccines & Prevention, on 'recalibrating' public understanding of illness

- PMLiVE

Janssen’s quest to prevent diseases taking hold

Johan van Hoof, general manager of Janssen Vaccines & Prevention, on 'recalibrating' public understanding of illness

Over two thirds of UK residents don’t believe that the state will be able to provide for their healthcare needs in later life

One of the findings of a new report by Health Unlimited and Foresight Factory.

Health Unlimited

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links